Member Info for C1p2D

But a little update would seem to be in order about now...

From a turd circling the bowl to possibly the most exciting sp ride going.

18% down one minute, 25% up the next.

Interesting to see what will happen if a really meaty rns lands...

Obvious, but every time they dilute, it will need evermore spectacular resuĺts for diminishing impact.

The shares in issue her are the barrier to this delivering a decent sp.

Every dilution just puts this further and further in a hole.

...

The conduit merger has always been a side hustle, i certainly didn't invest for it .

Maybe its worth a short term spike for beer tokens, but let's be honest, after that spike it will settle down again while we wait for the main course.

Untwist your knickers, unlike covid vaccines, real biotech stuff takes a while to do properly...

Anyone clued up on what the charts are implying?

Cheers

Not worrying about this drop here - 4 off my shares are all down 10% at the moment.

Feels like it could just be one of those śh1t days...

We get out of dodge without it dropping much more. You could say a good opportunity to average down - think I'll hold fire for the moment

Pretty clear now why AH is has been busting a gut to get to Queensland

Not the day to tell everyone what a bargain this is...

Not sure where you've crawled out from, somewhere unpleasant probably - guessing you're here because you enjoy trolling and have nothing better to do.

Oh well, simple things and all that eh...

Speed, however, is of the essence.

There is a lot to go at, but we do need something tangible reasonably soon - yes we are "fully funded" (usual ECR caveats there) but stating the obvious, if we raise before the sp has moved significantly north from here it means each subsequent result needs to be ever more impressive...

Remember - Pfizer were happy to pay billions in fines as the cost of doing business...

i'd agree that if the ciz tech pans out as we hope, we can expect some early offers to buy out.

the question is what qualifies as cheap?

how much of a threat is a potential ciz test to the revenues that the bigger pharmas currently make from ongoing treatments?

genuine question- i don't know the answer.

my thoughts are that actually they make a **** ton of money from the ****tails of drugs that people with stage 3/4 cancers have to take - the chemo, then the drugs to deal with the side-effects, then the drugs to deal with those side effects and the ongoing repeated scans etc,etc,etc.

it's a license to print money - its no secret that treatment is always more profitable than a cure...

if our test was to save, for example, the nhs £100m a year, we have to understand that a lot of the £100m would of been going to big pharma.

rhetorical question - will they be happy with that?

another rhetorical question - is big pharma in it to maximise lives saved?

in the us its completely different - its all about the money, not saving it.

our test could potentially threaten any/all of the pharmas involved with cancer treatment.

so - what is "cheap"?

is , for example, £1.4b (so £4/share at circa 350m shares in issue) cheap if you protect ongoing yearly revenues of multiples of that?

Fair enough Joe - each to their own and what works for them.

Joe, i don't think LTH means what you think it means...

Talking about pump & dumps when the share is moving fractions of a penny - you're clearly not a"LTH", more like a day trader.

The plan here has been laid out by the chairman, it's pretty clear and they have not at any point promised anyone a quick buck.

Have you thought about smallcap miners instead? There's all kinds of bullsh1it shenanigans in that sector if you want silly volatility on nothing.

Otherwise, chill, relax and wait for the real gains when (caveat - if, of course) we bring a 90%+ accurate, cheap, simple test that detects stage 1 lung cancer to market.

Fractions of a penny...

Side hustle, no?

Spot on Jace. Worrying about movements of fractions of a penny - that's day trading, not investing.

I'm not here for pennies.

A simple, fast and accessible test that can detect stage one lung cancer with 90% accuracy (before it potentially detects other cancers too)

That's not pennies.

Feels like the ship has been turned in a new direction now - the potential ( caveat - "potential") really does feel exciting, multiple prospects and opportunities at Lolworth to go at over a big area. Looking forward to see what they find.

$65.4m atm